Archive for March, 2020

$POAI Enters Securities Purchase Agreement to Raise $3.5M through Private Placement

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, this morning announced its entrance into a securities purchase agreement with certain accredited investors to raise $3.5 million through the issuance of up to 1,650,165 shares of common stock or common stock equivalents and accompanying warrants to purchase a total of up to 3,300,330 shares of common stock at a price of $2.121 each. The warrants will be exercisable immediately at an exercise price of $1.88 each, with one-half of the warrants to expire two years after the date of issuance, and the remaining half to expire five and one-half years after the date of issuance. The closing of the private placement is subject to the satisfaction of customary closing conditions in accordance with the securities purchase agreement. Predictive Oncology plans to use the net proceeds for general corporate purposes. Per an agreement with the investors, Predictive Oncology is required to file an initial registration statement with the Securities and Exchange Commission (“SEC”) covering the resale of the shares to be issued to the investors no later than thirty days after the closing and to have the registration statement declared effective no later than 90 days after today in the event of a “full review” by the SEC.

To view the full press release, visit http://nnw.fm/4nfDM

About Predictive Oncology Inc.

Predictive Oncology (NASDAQ: POAI) operates through three segments (Domestic, International and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://nnw.fm/POAI

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Monday, March 16th, 2020 Uncategorized Comments Off on $POAI Enters Securities Purchase Agreement to Raise $3.5M through Private Placement

$BHAT to Report Q4, Full Year 2019 Financial Results and Host Earnings Call

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, today announced that it will report its fourth quarter and full year 2019 unaudited financial results before the U.S. markets open on Monday, March 23, 2020. According to the update, Blue Hat’s management will host an earnings conference call on March 23 at 8:00 AM ET (8:00 PM Beijing/Hong Kong Time). Interested parties may join the call by dialing +1-845-675-0437 (U.S./International), +852-3018-6771 (Hong Kong) or 400-620-8038 (Mainland China) and entering passcode 4375563. A conference replay may be accessed after the call and until Tuesday, March 31, 2020, by dialing +1-855-452-5696 (U.S./International), 800-963-117 (Hong Kong) or 400-632-2162 (Mainland China) and entering passcode 4375563.

To view the full press release, visit http://nnw.fm/tr04T

About Blue Hat

Blue Hat Interactive Entertainment Technology is a producer, developer and operator of AR interactive entertainment games and toys in China, including interactive educational materials, mobile games, and toys with mobile game features. The company’s interactive entertainment platform creates unique user experiences by connecting physical items to mobile devices, which creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. Distinguished by its own proprietary technology, Blue Hat aims to create an engaging, interactive and immersive community for its users. For more information, visit the company’s website at www.BlueHatGroup.net.

NOTE TO INVESTORS: The latest news and updates relating to BHAT are available in the company’s newsroom at http://nnw.fm/BHAT

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Friday, March 13th, 2020 Uncategorized Comments Off on $BHAT to Report Q4, Full Year 2019 Financial Results and Host Earnings Call

$POAI AI/ML Expertise, Recent Acquisition Invaluable for New Anti-Virals, Vaccines

March 13, 2020

  • POAI positioned as leader in using data, artificial intelligence in search for novel effective treatments
  • Planned acquisition provides Predictive Oncology with CoRE(TM), a proven machine-learning framework
  • Uniting CoRE with proprietary PDx tumor-profiling platform and tumor-data database creates one-of-a-kind, end-to-end “discovery machine”

With its recent proposed acquisition of Carnegie Mellon spin-out Quantitative Medicine, Predictive Oncology Inc. (NASDAQ: POAI), a leader in using data and artificial intelligence (AI) to develop personalized cancer therapies, demonstrates its strong position in assisting in the search for new anti-cancers, anti-virals, antibiotics and vaccines. POAI’s expertise in this area is particularly relevant in light of the current race to learn more about the novel coronavirus 2019-nCoV and identify potential treatments, including vaccines, to fight the COVID-19 disease.

As organizations around the world rush to find ways to slow the spread of the COVID-19 outbreak, the importance of AI and machine learning (ML) in the world of today’s medicine has become increasingly clear (http://nnw.fm/JPuI6). Governments, pharmaceutical companies, universities and others are united in their focus to develop new diagnostics, vaccines and drug therapies aimed at the 2019-nCoV virus.

Announcements from Insilico Medicine and MIT point to the increasing importance of AI and ML in the progress of modern medicine. In addition, both studies relied on AI and ML approaches that are similar to the CoRE technology used by QM, which POAI is working to acquire (http://nnw.fm/G2t12). With an agreement in principal in place, the all-stock acquisition is expected to close this month.

This planned acquisition provides POAI with QM’s proven machine-learning framework, called CoRE. Developed at CMU and exclusively licensed to QM, CoRE is a predictive model-building platform for drug screening and optimization campaigns that uses hybrid machine-learning approaches to rapidly build predictive models to drive wet-lab experimentation.

Uniting the CoRE approach with the proprietary PDx tumor-profiling platform and tumor-data database owned by POAI subsidiary Helomics allows for a one-of-a-kind, end-to-end “discovery machine” (http://nnw.fm/gIXC7). This approach will “rapidly and cost-effectively generate potential therapeutic candidates that demonstrate activity against the disease. Therapeutic candidates developed by this iterative AI and experiment cycle can be fast-tracked, since there is already demonstrated activity in preclinical laboratory tests rather than just a computer model.”

Although POAI’s current focus is on cancers, the CoRE discovery machine could easily be utilized in other critical research, including the rapid discovery of therapeutics, such as anti-virals. “Given sufficient resources and access to relevant data, POAI’s CoRE-driven Helomics discovery machine could soon be at the forefront of the fight against these new viruses,” POAI’s release noted.

The impact of this collaboration on the healthcare industry – between POAI’s AI expertise and QM’s CoRe platform – looms large. Insilico Medicine and MIT illustrate the critical part AI and ML play in the process of advancing modern medicine. In its announcement, Insilico Medicine shared molecular structures potentially to targeting the key protein of 2019nCoV. “By making these structures available to the general public, Insilico hopes those who are interested in finding a potential treatment for this viral infection could synthesize and test these molecules,” the announcement said (http://nnw.fm/Kmh1P). Insilico will also “synthesize and test up to 100 molecules using its own resources and the resources generously offered by its closest partners, to contribute to the global effort.”

For its part, MIT used an MI algorithm to identify a powerful new antibiotic compound that “killed many of the world’s most problematic disease-causing bacteria, including some strains that are resistant to all known antibiotics,” MIT researchers announced (http://nnw.fm/Qcr02). “It also cleared infections in two different mouse models. The computer model, which can screen more than a hundred million chemical compounds in a matter of days, is designed to pick out potential antibiotics that kill bacteria using different mechanisms than those of existing drugs.” As healthcare industry leaders continue to harness the power of AI and ML technologies to improve patient outcomes, the demand for reliable, data-rich platforms like that of POAI is only expect to grow.

POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through its Helomics division, the company leverages its unique, clinically validated patient derived (PDx) smart tumor profiling platform to provide oncologists with a roadmap to help individualize therapy. In addition, the company is leveraging artificial intelligence and its proprietary database of over 150,000 cancer cases tumors to build AI-driven predictive models of tumor drug repose to improve outcomes for the patients of today and tomorrow.

For more information, visit the company’s website at www.Predictive-Oncology.com

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://nnw.fm/POAI

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Friday, March 13th, 2020 Uncategorized Comments Off on $POAI AI/ML Expertise, Recent Acquisition Invaluable for New Anti-Virals, Vaccines

$SRAX Implements Growth Strategy for 2020

Digital-marketing and consumer-data-management technology company SRAX (NASDAQ: SRAX) CEO Chris Miglino recently discussed the company’s strategy for 2020 in an exclusive interview with NNW’s Stuart Smith (http://nnw.fm/9JOi4). An article discussing the company reads, “Miglino pointed out that the year has already started strong as SRAX announced in January that it partnered with Experian to offer financial services to BIGtoken users (http://nnw.fm/MDec1), a deal that Miglino expects to be a big revenue generator both for SRAX and Experian. . . . Speaking about SRAX’s outlook for 2020, Miglino said that the company established powerful partnerships with both publishers and marketers to bring people on to the BIGtoken platform. As a result, the company expects an increasing number of consumers to join the platform, while SRAX IR anticipates continued growth of recurring revenue streams. ‘Both platforms are keyed up now to start contributing to the company financially,’ said Miglino. ‘As we move from the development cycle to the revenue cycle, we are very excited about that.’”

To view the full article, visit http://nnw.fm/ag0BC

About SRAX Inc.

SRAX Inc. (NASDAQ: SRAX) is a digital-marketing and consumer-data-management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and the characteristics of those consumers across marketing channels. Monetizing its data sets, SRAX is growing multiple recurring revenue streams through various platforms. Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby offering everyone in the internet ecosystem choice, transparency and compensation. SRAX’s tools deliver a digital competitive advantage for brands in the CPG, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform. For more information, visit the company’s website at www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Friday, March 13th, 2020 Uncategorized Comments Off on $SRAX Implements Growth Strategy for 2020

$JMDA Vocal Platform Generates Value for Creators, Brands and Readers

Jerrick Media Holdings’ (OTCQB: JMDA) exclusive platform for digital creators, Vocal, has formed a strong virtuous cycle intended to support and reward creators, brands and readers alike. A recent article discussing the company reads, “At the core of Jerrick’s virtuous cycle is the company’s commitment to and understanding of virtuous ecosystems, a concept that Harvard Business Review (http://nnw.fm/K44Jc) describes as ‘perhaps the single most important algorithmic distinction between ‘born digital’ enterprises and legacy companies… a clear real-time commitment to delivering accurate, actionable customer recommendations.’ . . . ‘Recommendation engines (or recommenders) force organizations to fundamentally rethink how to get greater value from their data while creating greater value for their customers,’ explained the HBR article, titled ‘Great Digital Companies Build Great Recommendation Engines’. Certainly, Jerrick’s Vocal platform fits the article’s analysis that ‘recommenders’ true genius comes from their opportunity to build virtuous business cycles: The more people use them, the more valuable they become; the more valuable they become, the more people use them.’ Importantly, these so-called ‘recommendation engines’ aren’t just about recommending products for consumers to buy – rather, this term refers to platforms that enable all types of digital interaction. ‘Appropriately designed,’ the article explains, ‘these interactions create value for your customer and for you. Virtuous cycles can become more virtuous and valuable.’”

To view the full article, visit http://nnw.fm/5Cyg6

About Jerrick

Jerrick is a holding company that develops technology-based solutions. Its flagship product — Vocal — is a long-form, digital-publishing platform focused on supporting content creators by providing them with publishing tools and monetization features that are embedded within digital communities. Vocal is architected to enable targeted marketing of branded content and e-commerce opportunities embedded within long-form content. Vocal’s community sites are managed by a dedicated team, whose primary focus is on creating safe communities and identifying monetization opportunities within those communities. For more information, visit the company’s website at https://Jerrick.media.

NOTE TO INVESTORS: The latest news and updates relating to JMDA are available in the company’s newsroom at http://nnw.fm/JMDA

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Friday, March 13th, 2020 Uncategorized Comments Off on $JMDA Vocal Platform Generates Value for Creators, Brands and Readers

$SGLB Inks Commercialization Deal with Controls Innovator Materialise NV

March 13, 2020

  • Sigma Labs enters Joint Sales Agreement with industry leader Materialise to integrate, commercialize Sigma Labs’ Quality Assurance technology
  • Momentous industry collaboration validates 3rd party in-process quality assurance’s critical role in adoption, acceleration of metal additive manufacturing (AM)
  • SGLB’s PrintRite3D(R) is the only known technology that uniquely detects, identifies defects and anomalies real-time during 3D printing process of metal parts
  • Sigma Labs looks to snag significant segment of an untapped $2 billion market

In a groundbreaking press release (http://nnw.fm/mCZ4f), Sigma Labs Inc. (NASDAQ: SGLB) announced a joint sales agreement to commercialize SGLB’s PrintRite3D Quality Assurance technology which has been integrated with the Materialise Control Platform. Materialize NV (NASDAQ: MTLS) is a recognized global leader in 3D-printing software and advanced 3D printing services. The widely used Materialise Control Platform is an embedded hardware and software solution that provides better control over the additive manufacturing (AM) process by giving full control to the end-user.

Just last November, Sigma Labs demonstrated the latest version of its proprietary PrintRite3D Real-Time Melt Pool Analytics software platform in conjunction with Materialise at the Formnext 2019 conference in Frankfurt (http://nnw.fm/9ui8U). Since then, the companies have achieved integration of their products and now will offer a unique product solution for the entire metal additive manufacturing market: the retrofit of existing AM machines, OEM machine integration and closed loop control.

A myriad of variables, from machines to materials, create production challenges in AM. The inability to know the quality of finished products until postproduction and the uncertainty of parts being produced with consistency has limited companies’ ability to scale and has severely limited the widespread adoption of additive manufacturing.

Sigma Labs is determined to change that uncertainty by using artificial intelligence (AI) to predict flaws in the meltpool during production, providing quality assurance in-process, rather than post-process. Sigma’s PrintRite3D uniquely leverages thermal signatures to monitor the quality of each part in the production process – layer by layer and in real time. This allows operators to correct or stop production of a defective part, resulting in reduced error rates and higher yields. This incredibly sophisticated and powerful technology holds tremendous value for the 3D metal printing industry, and the Materialise agreement is a clear recognition of the value.

The agreement marks the first time a 3rd party in-process quality assurance software has been integrated and embedded in an AM platform, and perhaps more importantly, the agreement also marks the launch of Sigma Labs into commercialization. Founded in 2010 by a team of Los Alamos scientists, physicists and metallurgists, Sigma Labs has undergone extensive testing and validation of efficacy, earning high marks from all parties along the way.

SGLB is in an enviable position with a market projected to exceed $2 billion dollars, based on just the estimated number of 3D metal printers shipped between 2021 and 2027. Even more significant is Sigma’s competitive role in the $2 billion market, as no comparable is known to exist. Sigma Labs is the sole provider of real-time, in-process quality control software for the metal additive manufacturing market. Beyond the looming existing market, 3D printing is booming and projected to grow at a CAGR of 32.5% from 2019 to 2020 – and Sigma should be able ride the crest of that wave as well.

A large untapped market in search of solutions, a big technological head start, strategic partnerships and alliances in place, multiple patents awarded with more pending, and a reputation as the leading technology with significant barriers to entry from competition, Sigma Labs now surges to expand commercialization.

For more information about Sigma Labs, please visit www.SigmaLabsInc.com

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://nnw.fm/SGLB

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Friday, March 13th, 2020 Uncategorized Comments Off on $SGLB Inks Commercialization Deal with Controls Innovator Materialise NV

$YGYI Exploring Divestiture of Direct Selling Business Unit to Original Founders

Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise and a commercial hemp enterprise, today announced that it is exploring the divestiture of its direct selling business unit back to the original founders of the direct selling division. According to the update, YGYI has entered into a non-binding term sheet regarding a potential transaction with Steve and Michelle Wallach, and its board of directors has formed a special committee consisting of all of its independent directors to review and consider the terms of the proposed transaction. An investment banking firm has been engaged by the special committee to review the fairness of the proposed transaction to stockholders. “I believe that the potential of this divestiture strengthens the opportunity for all stakeholders and the focus that this will bring to the various divisions will allow both the public company and the direct selling division to thrive and better leverage their core competencies. The sales and supply agreements that will exist between the two entities, post divestiture, should allow for a seamless transition that benefits both companies,” Youngevity CEO Steve Wallach said in the news release. “The trust and respect and the strong relationship we have built with our President and CFO, Dave Briskie, provides us with a great deal of optimism that this potential transaction can provide a long-term beneficial relationship between our companies and all stakeholders.”

To view the full press release, visit http://cnw.fm/Z5Owj

About Youngevity International

Youngevity International, Inc. (NASDAQ: YGYI), is a multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise, a commercial hemp enterprise, and a multi-vertical omni direct selling enterprise. The company features a multi country selling network and has assembled a virtual main street of products and services under one corporate entity, YGYI offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. For more information, visit the company’s website at www.YGYI.com.

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://cnw.fm/YGYI

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

Thursday, March 12th, 2020 Uncategorized Comments Off on $YGYI Exploring Divestiture of Direct Selling Business Unit to Original Founders

$PBIO Order for Game-Changing UST System from $CANBD

Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced its receipt of a purchase order from a new customer, Can B Corp. (OTCQB: CANBD). According to the update, the order is for one of PBIO’s proprietary BaroShear K45 Ultra Shear Technology(TM) (“UST”)-based systems for processing CBD oil into stable, effectively water-soluble, highly absorbable nanoemulsions of oil in water. The nanoemulsions are expected to exhibit bioavailability levels that far exceed the absorption efficiency of today’s macro or microemulsions of CBD oil. “Importantly, the optimized effectiveness for the consumer also translates into allowing top-shelf manufacturers like Can B Corp to achieve targeted product effects from much lower levels of cannabinoids in their marketed products,” Pressure BioSciences President and CEO Richard T. Schumacher said in the news release. “This should offer them a dramatic new cost efficiency, for both ingested or topically applied products. We also believe that Can B Corp’s routine use of our BaroShear K45 system will allow them to increase even more the current high-quality level of their products.”

To view the full press release, visit http://cnw.fm/yRmn8

About Pressure BioSciences Inc.

Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented, enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). PBIO’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired, patented technology from BaroFold Inc. (the “BaroFold” technology) to allow entry into the biopharma contract services sector, and (2) the use of its recently patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room-temperature, stable low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

Thursday, March 12th, 2020 Uncategorized Comments Off on $PBIO Order for Game-Changing UST System from $CANBD

$POAI New AI Platform for Vaccine Development in COVID-19, MERS and SARS

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced its plans to launch a new AI platform for vaccine and drug development targeting Coronaviruses and Acute Respiratory Syndromes (COVID-19, MERS and SARS) through an operating agreement with Soluble Therapeutics.  According to the update, POAI has also signed a letter of intent with InventaBioTech to acquire Soluble Therapeutics, its assets and its HSCTM Technology. As global health experts predict an ever-increasing number of viral outbreaks like COVID-19, POAI is taking proactive measures to be part of the solution by applying artificial intelligence to aid in the development of new drugs and vaccines. Soluble’s computer system, utilizing its HSCTM technology and six machines, is expected to be able to run over 12,000 computer simulations per machine to help generate new diagnostics, vaccines and therapeutics. “Soluble has six customized machines in its facilities that can help identify the best solutions for vaccines, proteins or antibodies being developed to help fight the COVID-19 contagion,” Predictive Oncology CEO Carl Schwartz said in the news release. “Through this operating partnership and acquisition, we are ready to assist in the development of viable treatment options that use biological, complex ingredients and formulations to speed up the pre-clinical and clinical development of treatments.”

To view the full press release, visit http://nnw.fm/RS3Nf

About Predictive Oncology Inc.

Predictive Oncology (NASDAQ: POAI) operates through three segments (Domestic, International and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://nnw.fm/POAI

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Thursday, March 12th, 2020 Uncategorized Comments Off on $POAI New AI Platform for Vaccine Development in COVID-19, MERS and SARS

$CNPOF $RIV & $WEED $CGC C$80.5M Debt Financing Arrangement

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Wednesday announced that TerrAscend Canada Inc., a wholly owned subsidiary of CNPOF’s portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF), has entered into an C$80.5 million loan financing arrangement with Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) pursuant to a secured debenture. TerrAscend has issued 17,808,975 common share purchase warrants to Canopy Growth in connection with the loan. TerrAscend Canada intends to use the net proceeds toward general corporate purposes, the funding of its Canadian operations, its Arise Bioscience U.S. hemp division, international expansion, and the repayment of indebtedness. “This additional capital is a vote of confidence in TerrAscend Canada’s ability to execute on its strategic mandate for both domestic and international markets,” Canopy Rivers president and CEO Narbe Alexandrian stated in the news release. “We believe the TerrAscend team is well-positioned through their resources and network to continue to take advantage of opportunities in regulated jurisdictions. We are also pleased with Canopy Growth’s continued support of our portfolio companies.”

To view the full press release, visit http://cnw.fm/2vXSL

About Canopy Rivers

Canopy Rivers is a venture capital firm specializing in cannabis. Its unique investment and operating platform is structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire portfolio. For more information, visit www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/CNPOF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Thursday, March 12th, 2020 Uncategorized Comments Off on $CNPOF $RIV & $WEED $CGC C$80.5M Debt Financing Arrangement

$MEDS Subsidiaries’ Visionary Telehealth Services Help Limit Impact of Global Viruses

March 11, 2020

  • Pioneering supplier-to-pharmacy tech platform builder Trxade Group Inc. helps small, community-based pharmaceutical businesses be competitive with larger chains by sourcing drugs at discount prices and promoting transparency in business operations
  • Trxade Group has been developing its subscribers’ access to licensed medical professionals through telehealth services that are both convenient to the patient and significant in their ability to limit the number of people visiting hospitals and offices
  • Amid the sweeping, deadly impact of the seasonal flu and the rising novel coronavirus epidemic, Trxade’s online access to physicians is a timely preventative service
  • Trxade Group Inc. recently announced its uplisting to the Nasdaq Capital Market and rang the exchange’s opening bell, changing its ticker from ‘TRXD’ to ‘MEDS’
  • The company’s network of pharmaceutical partners continues to grow, serving a large percentage of the nation’s 24,000 independent pharmacies

Innovative B2B health services provider Trxade Group Inc. (NASDAQ: MEDS) is helping to reduce exposure to deadly viruses sweeping the planet through the patient empowerment actions of its wholly owned subsidiaries.

As seasonal flu virus infections continue to claim the lives of tens of thousands of Americans and hospitalizes hundreds of thousands of people worldwide (http://nnw.fm/vsI9O), the rise and spread of the novel coronavirus COVID-19 has drawn attention to international measures to stop a deadly, vaccine-less illness by first locking down an entire province (in China), and most recently an entire nation (in Italy), while other communities worldwide close public gathering venues or attempt to assure attendees that adequate health measures are being taken to limit their exposure to such viruses (http://nnw.fm/6ASjE).

Trxade Group’s support of community-based, independent pharmacies, as well as the acquisition of Community Specialty Pharmacy’s online access operation last year (http://nnw.fm/lIW5E) and the establishment of the “Bonum Health Hub” online portal initiative this year (http://nnw.fm/7Xw4G) seems almost prescient in nature given the viral outbreaks’ impact even on access to hospital facilities and their providers (http://nnw.fm/wHRR5).

On March 10, Trxade Group announced the launch of a new membership service by its virtual healthcare subsidiary Bonum Health and its DelivMeds concierge medication delivery operation. The new service allows subscribers to obtain three premium medical teleconferencing visits and free prescription delivery per month, according to a company news release (http://nnw.fm/d32UE).

Bonum’s telehealth services utilize patients’ personal smart tech devices in a private, HIPPA compliant manner that delivers access to board-certified physicians from virtually anywhere the patient may choose to be.

“Teleconferencing with a board-certified provider for assurance via online consultation is quick, easy, and relatively inexpensive. These services free patients from unnecessary exposure or resorting to urgent care facilities and hospital emergency rooms,” Trxade Group’s news release states. “With the seasonal flu outbreaks and the current coronavirus surge, patients are quick to brush off common symptoms, including cough, fever and body aches, as signs of a common cold; Telemedicine removes the barrier of self-doubt and complacency in the current climate of world-wide viral infections.”

Trxade Group is building a growing platform of integrated drug procurement, delivery and healthcare services to facilitate price transparency and increased profit margins for independent pharmacies within its network as well as pharmaceutical product sellers.

The company recently uplisted its common stock to the Nasdaq Capital Market, while also announcing it expected gross proceeds of $5.2 million from the sale of common stock in a public offering (http://nnw.fm/Yhg4C).

For more information, visit the company’s website at www.TrxadeGroup.com

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://nnw.fm/MEDS

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Wednesday, March 11th, 2020 Uncategorized Comments Off on $MEDS Subsidiaries’ Visionary Telehealth Services Help Limit Impact of Global Viruses

$SGLB Signs Joint Sales Agreement with Leading Provider of 3D Printing Controls Software

March 11, 2020

  • Sigma Labs, Materialise joint sales agreement calls for product commercialization
  • Earlier MOU outlined integration of Materialise MCP Controller, SGLB PrintRite3D(R) technology
  • Exclusive product expected to lower additive manufacturing costs, improve yield and profit margin, lead to closed loop control

Sigma Labs Inc. (NASDAQ: SGLB), the only provider of in-process, quality-assurance software to the commercial 3D-metal- printing industry, has entered into a joint sales agreement with Materialise, a leading provider of additive manufacturing software and sophisticated 3D-printing services (http://nnw.fm/s7JCy).

An earlier memorandum of understanding provided a framework for the two companies to cooperate on the integration of the widely used Materialise MCP Controller with Sigma Labs’ PrintRite3D(R) technology, together creating an integrated PrintRite3D and Materialise Control Platform (MCP) product. The companies have now achieved integration and will begin offering a unique product solution for retrofit of existing machines, OEM machine integration and closed loop control. Commercialization of the 3D printing industry’s first in-process quality control software is expected to commence immediately.

“Growing our partnership with Materialise is a significant milestone for Sigma Labs as we expand our footprint in the market and add momentum to our quest to broaden industry access to our groundbreaking PrintRite3D software,” SGLB Executive Chairman Mark K. Ruport stated in a news release. “The alignment is a natural step for both companies, as Materialise has a strong presence in the additive manufacturing market and a reputation for quality products. Commercializing and jointly selling this integrated solution will benefit both companies as well as advance the forward momentum of innovation in the 3D-manufacturing industry.”

SGLB scientists, engineers and software developers developed proprietary hardware and software technology that uses thermal readings to detect and predict anomalies during the 3D-printing process. This technology, incorporated in Sigma Labs’ PrintRite3D software, features real-time monitoring, analysis, feedback and control that delivers impressive results.

When utilizing the software, end users can lower their additive manufacturing costs and improve yield and profit margin. The MCP is an embedded hardware and software solution that addresses the growing need for broader and more straightforward control over the additive manufacturing process by giving full control to the end-user.

Materialise brings together three decades of 3D-printing experience into a range of software solutions and 3D-printing services, which together form the backbone of the 3D-printing industry. Materialise’s open and flexible solutions enable players in a variety of industries, including healthcare, automotive, aerospace, art and design, and consumer goods, to build innovative 3D-printing applications designed to make the world a better and healthier place. Headquartered in Belgium with branches worldwide, Materialise combines the largest group of software developers in the industry with one of the largest 3D-printing facilities in the world.

Founded in 2010, Sigma is a software company that specializes in the development and commercialization of real-time, computer-aided-inspection (CAI) solutions known as PrintRite3D for 3D-advanced manufacturing technologies. SGLB’s advanced, computer-aided software product revolutionizes commercial additive manufacturing, enabling nondestructive quality assurance mid-production, uniquely allowing errors to be corrected in real time.

For more information about Sigma Labs, please visit www.SigmaLabsInc.com

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://nnw.fm/SGLB

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Wednesday, March 11th, 2020 Uncategorized Comments Off on $SGLB Signs Joint Sales Agreement with Leading Provider of 3D Printing Controls Software

$BHAT Secures US Patent for “Interactive System Based on Light Intensity Recognition”

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, today announced the United States Patent and Trademark Office’s issuance of U.S. patent number US 10,512,836 B2, covering Blue Hat’s “Interactive System Based on Light Intensity Recognition.” According to the update, the Blue Hat system connects a physical toy with the virtual content of a mobile game, which the Company believes represents a major breakthrough in the realization of AR technology. Blue Hat’s AR Racer product is a prominent example of the potential presented by its “Interactive System Based on Light Intensity Recognition.” “We believe that the success of our AR Racer product, which incorporates our ‘Interactive System Based on Light Intensity Recognition,’ is testament to this technology’s popularity among consumers,” Blue Hat Chief Executive Officer Xiaodong Chen said in the news release. “Looking ahead, we intend to develop a wide range of products incorporating this technology to further implement our goal of creating a rich visual and interactive environment for our users, and we intend to ramp up our overseas expansion and continue discussions with distribution partners in the U.S.”

To view the full press release, visit http://nnw.fm/g0xYx

About Blue Hat

Blue Hat Interactive Entertainment Technology is a producer, developer and operator of AR interactive entertainment games and toys in China, including interactive educational materials, mobile games, and toys with mobile game features. The company’s interactive entertainment platform creates unique user experiences by connecting physical items to mobile devices, which creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. Distinguished by its own proprietary technology, Blue Hat aims to create an engaging, interactive and immersive community for its users. For more information, visit the company’s website at www.BlueHatGroup.net.

NOTE TO INVESTORS: The latest news and updates relating to BHAT are available in the company’s newsroom at http://nnw.fm/BHAT

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Wednesday, March 11th, 2020 Uncategorized Comments Off on $BHAT Secures US Patent for “Interactive System Based on Light Intensity Recognition”

$MEDS Announces New Membership Service by Bonum Health and DelivMeds Subsidiaries

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced the onset of a new membership service by its subsidiaries Bonum Health and DelivMeds. According to the update, the monthly subscription rate of $19.95 now includes an option of three (3) premium visits per month as well as free prescription delivery service through its subsidiaries. A virtual healthcare subsidiary, Bonum Health provides telehealth services and prescription ordering via teleconferences that are routinely conducted using smart devices. The company provides a HIPPA compliant, dynamic way for patients to access board-certified physicians from the comfort of their homes or location of preference. DelivMeds is a concierge service that provides free prescribed medication delivery to patients via member independent pharmacies.

To view the full press release, visit http://nnw.fm/RgR9e

About Trxade Group, Inc.

Headquartered in Tampa, Florida, Trxade Group, Inc. (NASDAQ: MEDS) is an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals. Founded in 2010, Trxade Group is comprised of three synergistic operating platforms; the Trxade B2B trading platform with 11,900 registered pharmacies, licensed virtual Wholesale and Mail Order Pharmacy delivery capabilities using DelivMeds app. For additional information, please visit www.Trxade.com, www.DelivMeds.com and www.BonumHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://nnw.fm/MEDS

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Tuesday, March 10th, 2020 Uncategorized Comments Off on $MEDS Announces New Membership Service by Bonum Health and DelivMeds Subsidiaries

$PBIO Opens UST Demo Lab, Ushering in New Era in CBD Water-Soluble Nanoemulsion Prep

March 10, 2020

  • The new facility is designed to demonstrate the company’s innovative Ultra Shear Technology’s ability to create CBD oil nanoemulsions of superior stability, aesthetics, and bioavailability
  • Company has received orders for nine UST-based BaroShear K45 proprietary systems, with three more anticipated shortly, for an overall value of $2.4 million
  • Global nanoemulsion market estimated to rise to $14.91 billion by the end of 2025

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, and other industries, recently announced the opening of their new Ultra Shear Technology(TM) Demonstration Laboratory, located in the company’s South Easton, MA facility (http://nnw.fm/5Ic0n).

The main goal of the UST Demo Lab is to showcase the ability of the company’s revolutionary UST Platform to process cannabidiol (CBD) oil into water-soluble nanoemulsions of superior quality. CBD nanoemulsions are expected to be more stable and offer higher bioavailability than the standard macro and microemulsions used in the vast majority of CBD products today.

The second objective is to invite potential purchasers of the company’s BaroShear nanoemulsification system to evaluate how their CBD and other product formulations work with the company’s revolutionary UST platform. The company expects to install and invoice the initial 12 BaroShear K45 systems in the fourth quarter of 2020.

CBD and other cannabinoids are extracted from hemp in an oil form. As with any oil-based product, it is difficult for the water-based biology of the human body to access and absorb CBD molecules from relatively large hemp oil drops. This varying, poor absorption of CBD results in reduced bioavailability of the CBD molecule in the body. Low or widely varying absorption levels and bioavailability of CBD have a negative impact on the effective delivery of many CBD products’ potential benefits.

“We processed samples of CBD oil formulations from several highly interested companies over the past two months, in an effort to optimize the service we announced today,” Kenneth F. Micciche, UST Program director, stated in a news release. “The ability to showcase the UST platform in real life, and see the final product first-hand, has been shown to be vital to our marketing efforts. The opening of the UST Demo Lab is a critical accomplishment in our UST sales and marketing strategy.”

The UST Platform’s efficiency has already brought Pressure BioSciences several orders for the proprietary UST-based BaroShear K45 Systems. On January 24, the company announced it had received an order for six BaroShear K45 systems from Vegas CBD Factory, to be delivered and installed in the fourth quarter of 2020. This brings the total number of systems on order to nine and, what’s more, the company expects additional orders shortly. When these are received, the planned initial build of 12 systems will sell out with approximate total value of $2.4 million (http://nnw.fm/P0TdC).

In addition to CBD, Pressure BioSciences’ innovative pressure-based instruments are also used successfully in many different healthcare areas, such as supporting important research studies in new treatments for cancer, stroke, heart disease, infectious diseases and Alzheimer’s. UST therefore has the potential to have a significant impact in many multi-billion-dollar markets in addition to cannabis, such as cosmetics, nutraceuticals, pharmaceuticals, and foods and beverages.

The company is also uniquely positioned to leverage an increasing number of opportunities on the fast-growing nanoemulsion market. According to Transparency Market Research, the market will see exponential growth over the next few years, being expected to reach $14.91 billion by the end of 2025 from $6.78 billion in 2016 (http://nnw.fm/9qyOP).

For more information, visit the company’s website at www.PressureBioSciences.com

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://nnw.fm/PBIO

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Tuesday, March 10th, 2020 Uncategorized Comments Off on $PBIO Opens UST Demo Lab, Ushering in New Era in CBD Water-Soluble Nanoemulsion Prep

$POAI Appoints New Board Member with Impressive CSO, Senior Research Background

March 10, 2020

  • Dan Handley brings wealth of invaluable experience to POAI’s board of directors
  • Newest board member has extensive experience with entities closely associated with POAI’s Helomics division
  • Predictive Oncology set to benefit from Handley’s broad knowledge, expertise

Predictive Oncology Inc. (NASDAQ: POAI), a leader in the cancer precision-medicine field, has announced the unanimous appointment of its newest board member (http://nnw.fm/TlGT0). Dr. Dan Handley, MS, PhD, brings a wealth of invaluable experience to POAI’s already impressive board of directors.

“Predictive Oncology is once again very fortunate to announce another exemplary addition to our Board of Directors,” POAI CEO Dr. Carl Schwartz stated in a news release. “Dan Handley has a varied and strong background, including interaction with Carnegie Mellon University and Magee-Women’s Research Institute – both leaders in their respective fields and closely associated with our Helomics division. I greatly anticipate working with Dan and benefitting from his knowledge and experience.”

Currently serving as a professor and the director of the Clinical and Translational Genome Research Institute of Southern California University of Health Sciences, Handley has also served as chief scientific officer of the Clinical and Translational Genome Research Institute, a Florida 501(c)3 nonprofit corporation. During his time at the Genome Research Institute, Handley held a courtesy faculty appointment in the Department of Biological Sciences at Florida Gulf Coast University.

Other roles Handley has filled include chief scientific officer for Advanced Healthcare Technology Solutions Inc.; senior researcher at Procter & Gamble; senior administrator, researcher and laboratory manager at the David Geffen UCLA School of Medicine; and a founding biotechnology inventor for the National Genetics Institute.

Handley holds a BA in biophysics from Johns Hopkins University, an MS in logic and computation from Carnegie Mellon University and a PhD in human genetics from the University of Pittsburgh. In addition, he completed his postdoctoral training at Magee-Women’s Research Institute where his research focused on advanced genomic technologies applied to fetal and maternal health. A decorated veteran, Handley served as a nuclear propulsion instructor and a submarine nuclear reactor operator during his time with the U.S. Navy.

POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through its Helomics division, the company leverages its unique, clinically validated patient derived (PDx) smart tumor profiling platform to provide oncologists with a roadmap to help individualize therapy. In addition, the company is leveraging artificial intelligence and its proprietary database of over 150,000 cancer cases tumors to build AI-driven models of tumor drug repose to improve outcomes for the patients of today and tomorrow.

For more information, visit the company’s website at www.Predictive-Oncology.com

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://nnw.fm/POAI

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Tuesday, March 10th, 2020 Uncategorized Comments Off on $POAI Appoints New Board Member with Impressive CSO, Senior Research Background

$YGYI Subsidiary Secures Finance and Supply Agreement for 2020 Growing Season

Youngevity International (NASDAQ: YGYI) today announced its wholly owned subsidiary, CLR Roasters, has entered into a finance and supply agreement for the 2020 growing season with H&H Export Y CIA, LTDA, funded by H&H Export’s $46,500,000 credit facility. The credit line, which has been established by a Nicaraguan special purpose agency, is for the purchase of up to 49.5 million pounds, or 495,000 Quintals, of green coffee. CLR Roasters provided further collateral totaling a value of $11.1 million to secure the financing arrangement. CLR Roasters intends to process the green coffee beans for the 2020 growing season at its new, state of the art production facility, and expects to have the processing plant fully online by July. “This is a big deal for CLR. We believe we are now well positioned to exceed last year’s record revenue and profit numbers. Having these significant financial resources should be a key component for driving our 2020 green coffee program,” CLR Roasters president Ernesto Aguila stated in the news release.

To view the full press release, visit http://nnw.fm/C8exX

About Youngevity International

Youngevity International, Inc. (NASDAQ: YGYI), is a multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise, a commercial hemp enterprise, and a multi-vertical omni direct selling enterprise. The company features a multi country selling network and has assembled a virtual main street of products and services under one corporate entity, YGYI offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. For more information, visit the company’s website at www.YGYI.com.

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://nnw.fm/YGYI

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Monday, March 9th, 2020 Uncategorized Comments Off on $YGYI Subsidiary Secures Finance and Supply Agreement for 2020 Growing Season

$SGLB to Host Conference Call to Discuss Q4 and Full Year 2019 Results

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, today announced its plans to host a conference call at 4:30 p.m. Eastern Time on Tuesday, March 24, 2020, to discuss its results for the fourth quarter and full year ended December 31, 2019. Per the update, Sigma Labs Executive Chairman Mark Ruport, CEO John Rice and CFO Frank Orzechowski will lead the conference call, followed by a question and answer period. Interested parties may access the call by dialing 1-877-407-9039 (toll-free) or 1-201-689-8470 (international) and entering conference ID: 13700105. A conference call replay will be available after 7:30 p.m. Eastern Time through April 7, 2020, by dialing 1-844-512-2921 (toll-free) or 1-412-317-6671 (international) and entering replay ID: 13700105.

To view the full press release, visit http://nnw.fm/5HXs3

About Sigma Labs

Sigma Labs, Inc. (NASDAQ: SGLB) is a leading provider of quality assurance software to the commercial 3D printing industry under the PrintRite3D(R) brand. Founded in 2010, Sigma is a software company that specializes in the development and commercialization of real-time computer aided inspection (“CAI”) solutions known as PrintRite3D(R) for 3D advanced manufacturing technologies. Sigma Labs’ advanced computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance mid-production, uniquely allowing errors to be corrected in real-time. For more information, please visit www.SigmaLabsInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://nnw.fm/SGLB

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Monday, March 9th, 2020 Uncategorized Comments Off on $SGLB to Host Conference Call to Discuss Q4 and Full Year 2019 Results

$JMDA Vocal Platform Provides Direct-to-Consumer Brands Unique Marketing Opportunity

Jerrick Media Holdings (OTCQB: JMDA), through Vocal, its exclusive platform for digital creators, enables direct-to-consumer brands a unique opportunity to team up with real creators who have established audiences. A recent article discussing the company reads, “The future of marketing is clearly noninvasive. A 2019 Statista analysis (http://nnw.fm/XMi5x) indicated that 25.8% of internet users in the U.S. use some form of ad blocker, increased from 23.6% of users in 2017, and 20.6% of users in 2015, and is expected to continue to grow (http://nnw.fm/16gXS). Obviously, an advertising alternative is called for, and the shift seems evident: unlike interruptive advertising, branded content is 22 times more engaging than other content, and customers loyal to a brand spend up to two times as much on branded services. Moreover, brands must adapt to the modern consumer, one whose focus includes not only price and product availability but also a more holistic interest in a company’s story — its purpose, community and corporate responsibility efforts (http://nnw.fm/b5rDB). In short, brands need a way to engage on a more personal level with their consumer audiences to tell their stories — and Jerrick’s Vocal platform has provided a solution.”

To view the full article, visit http://nnw.fm/i9mF9

About Jerrick

Jerrick is a holding company that develops technology-based solutions. Its flagship product — Vocal — is a long-form, digital-publishing platform focused on supporting content creators by providing them with publishing tools and monetization features that are embedded within digital communities. Vocal is architected to enable targeted marketing of branded content and e-commerce opportunities embedded within long-form content. Vocal’s community sites are managed by a dedicated team, whose primary focus is on creating safe communities and identifying monetization opportunities within those communities. For more information, visit the company’s website at https://Jerrick.media.

NOTE TO INVESTORS: The latest news and updates relating to JMDA are available in the company’s newsroom at http://nnw.fm/JMDA

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Friday, March 6th, 2020 Uncategorized Comments Off on $JMDA Vocal Platform Provides Direct-to-Consumer Brands Unique Marketing Opportunity

$MEDS Captures Significant Independent Pharmacy Market, Continues Steady Growth in 2020

March 6, 2020

  • Trxade Group has captured nearly half of the independent pharmacy market with its web-based purchasing platform
  • “E-Bay/Kayak-like” Supplier-to-Pharmacy trading platform improves transaction processing between independent pharmacists and drug distributors
  • Predictive data analytics features, price visibility and profit optimization within the platform are critical as the general population ages

Trxade Group Inc. (NASDAQ: MEDS) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform for transactions between independent pharmacists and drug distributors; a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

The Florida-based Company’s Supplier-to-Pharmacy (“S2P”) trading platform helps independent pharmacies nationwide to identify the best available supplier prices for prescription drugs. With over 11,900 registered pharmacies already on the company’s network, and adding approximately 100 new pharmacies per month, Trxade’s aim is to ultimately reach most of the 24,000 independent pharmacies, with a combined annual purchasing power of over $92 billion.

Trxade targets these independent pharmacies and has demonstrated a significant first-mover advantage over competitors operating similar e-commerce platforms. The company credits effective analytics deployment for the results attained. Trxade leverages a robust, “E-Bay/Kayak-like” technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

The platform has experienced unparalleled success due to the fact that the company’s business model is designed to overcome general obstacles faced by the typical independent pharmacy. Trxade has found that these pharmacies average annual sales of approximately $3.5 million and the average age of an independent pharmacy owner is greater than 60. Further, independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The Trxade S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving them money by taking advantage of best purchase pricing.

As the general population ages, drug costs are paced to increase faster than overall health care costs and well above inflation. Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

The company’s operating strategy is also contributing to its bright outlook for 2020. Trxade’s web-based platform makes it safe, secure and easy to review drugs offered by various suppliers and select the most favorable deals. This increases supplier competition and effectively lowers prices for the pharmacies, enabling them to enjoy larger profit margins.

Information sharing through direct marketing, email marketing, and trade conference attendance, has resulted in the company’s current trend of adding more than 100 pharmacies per month to its user base.

User satisfaction is yet another factor driving success. Pharmacies now have access to quality pharmaceuticals at significant discounts and a large network of suppliers for sales and purchasing opportunities. The analytical and price comparison tools allow for educated buying and selling decisions, easier price comparisons of multiple suppliers with only one search and simplified ordering to suppliers of choice. Customer service is first-class, as Trxade offers close guidance and support to pharmacies for their five initial purchases.

The company believes investors, consumers and industry stakeholders are poised to benefit in the near term from its recent deployment of superior data analytics as well as a platform specifically tailored to current industry needs.

For more information, visit the company’s website at www.TrxadeGroup.com

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://nnw.fm/MEDS

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Friday, March 6th, 2020 Uncategorized Comments Off on $MEDS Captures Significant Independent Pharmacy Market, Continues Steady Growth in 2020

$SGLB Partners with Materialise NV for Complete Metal 3-D Printing Production Control

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, was recently featured in an article authored by Jim Vinoski on Forbes.com titled ‘Joint Sales Agreement To Boost Metal 3-D Printing Quality Assurance Tech Startup’. Among other highlights, the article discusses SGLB’s recent entrance into a binding joint sales agreement with Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services. Per the agreement, the companies will integrate Sigma’s PrintRite3D software with the Materialise Control Platform product, resulting in a complete metal 3-D printing production control solution. “We’re coming out of a long stretch of testing and validation,” Sigma president and CEO John Rice stated. “We’ve said that 2020 is the year when we finally take advantage of all that, and this announcement is a reflection of that.”

To view the full article, visit http://nnw.fm/V85q7

About Sigma Labs

Sigma Labs, Inc. (NASDAQ: SGLB) is a leading provider of quality assurance software to the commercial 3D printing industry under the PrintRite3D(R) brand. Founded in 2010, Sigma is a software company that specializes in the development and commercialization of real-time computer aided inspection (“CAI”) solutions known as PrintRite3D(R) for 3D advanced manufacturing technologies. Sigma Labs’ advanced computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance mid-production, uniquely allowing errors to be corrected in real-time. For more information, please visit www.SigmaLabsInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://nnw.fm/SGLB

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Friday, March 6th, 2020 Uncategorized Comments Off on $SGLB Partners with Materialise NV for Complete Metal 3-D Printing Production Control

$SRAX Enters Financing Agreement with B. Riley Financial, Inc. Affiliate

SRAX (NASDAQ: SRAX), a digital marketing and consumer data management technology company, today announced its entry into a secured term loan with an affiliate of B. Riley Financial, Inc. (“B. Riley”), a diversified financial services company which provides comprehensive business advisory and capital markets solutions through its subsidiaries. “We are excited to partner with B. Riley. The team is experienced and will help us take the next steps in executing our plan,” SRAX Founder and CEO Christopher Miglino said in the news release. “This financing will help fuel growth as both BIGtoken.com and SRAXir.com are gaining traction in their goals to be the leaders in their respective data businesses.”

To view the full press release, visit http://nnw.fm/ivN8U

About SRAX Inc.

SRAX Inc. (NASDAQ: SRAX) is a digital marketing and consumer-data-management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and the characteristics of those consumers across marketing channels. Monetizing its data sets, SRAX is growing multiple recurring revenue streams through various platforms. Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby offering everyone in the internet ecosystem choice, transparency and compensation. SRAX’s tools deliver a digital competitive advantage for brands in the CPG, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform. For more information on SRAX, visit www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Thursday, March 5th, 2020 Uncategorized Comments Off on $SRAX Enters Financing Agreement with B. Riley Financial, Inc. Affiliate

$GNPX Lead Researcher Behind its Diabetes Gene Therapy Featured in New Video Interview

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing treatments for cancer and other serious diseases, today announced that Dr. George Gittes, the lead researcher and Harvard graduate that developed Genprex’s new potentially curative diabetes gene therapy, was featured in a video interview discussing the therapy. According to the update, Dr. Gittes joined one of Proactive’s broadcast journalists to provide an overview of the gene therapy, how it works, how it may have the potential to help treat type 1 and type 2 diabetes, as well as next steps to move the gene therapy to the clinic. “We noticed that by gene therapy we could cause some of the cells in the pancreas that do not normally make insulin, but they are closely related to insulin cells, to turn into an insulin-producing cell,” Dr. Gittes, Co-Scientific Director and Professor of Surgery at the UPMC Children’s Hospital of Pittsburgh, said in the interview. “The real excitement came when we realized that when we did this in a mouse that normally reacts to its own insulin cells in the same way a juvenile diabetic or Type 1 diabetic does, it didn’t notice these [new] cells and left them alone for a long time without us doing anything else. It was just one treatment with a gene therapy, and they [the mice] were fine for months, which is exciting.”

To watch the full video interview, visit http://nnw.fm/VOm6k

To view the full press release, visit http://nnw.fm/bN3Di

About Genprex, Inc.

Genprex, Inc. is a clinical-stage gene therapy company developing potentially life-changing treatments for cancer and other serious diseases. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and other serious diseases who currently have limited treatment options. Genprex works with world-class institutions and collaborators to in-license and develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches for patients with cancer and other serious diseases. The company’s lead product candidate, Oncoprex(TM) immunogene therapy for non-small cell lung cancer (“NSCLC”), uses the company’s unique, proprietary platform which delivers cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. In January 2020, the FDA granted Fast Track Designation for Oncoprex in combination with AstraZeneca’s Tagrisso(R) for the treatment of NSCLC. For more information, please visit the company’s website at www.Genprex.com.

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://nnw.fm/GNPX

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Thursday, March 5th, 2020 Uncategorized Comments Off on $GNPX Lead Researcher Behind its Diabetes Gene Therapy Featured in New Video Interview

$MEDS to Exhibit at HIMSS 2020 Global Health Conference and Exhibition

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables drug availability, care services and price transparency for both pharmacists and consumers, today announced that it will exhibit at HIMSS 2020. The event, which will draw over 45,000 healthcare professionals, is slated to take place at the Orange County Convention center in Orlando, Florida from March 9-13. Trxade’s booth will be located in Exhibit Hall E, Booth (#7273), Kiosk (#13). Members from the company’s leadership team will be present and provide detailed DEMO and information on products including: DelivMeds and Bonum Health, demonstrating the latest advances in value-based remote patient care and pharmaceutical services, to bridge gaps where care is limited, enhance patient knowledge and improve healthcare management.

To view the full press release, visit http://nnw.fm/NKwU4

About Trxade Group, Inc.

Headquartered in Tampa, Florida, Trxade Group, Inc. (NASDAQ: MEDS) is an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, accessories and services. Founded in 2010, Trxade Group is comprised of three synergistic operating platforms; the Trxade B2B trading platform with 11,900 registered pharmacies, licensed virtual Wholesale and Mail Order Pharmacy capabilities including DelivMeds, as well as the newly acquired assets of Bonum Health. For additional information, please visit www.Trxade.com, www.DelivMeds.com and www.BonumHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://nnw.fm/MEDS

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Thursday, March 5th, 2020 Uncategorized Comments Off on $MEDS to Exhibit at HIMSS 2020 Global Health Conference and Exhibition

$POAI LOI for Acquisition of Biomedical Analytics with Novel Drug-Discovery Platform

March 5, 2020

  • POAI’s planned acquisition of Quantitative Medicine (QM) will revolutionize the way precision therapies are developed
  • QM’s CoRE platform predicts main effects of drugs on target molecules that mediate disease
  • Synergies created by acquisition support POAI’s efforts to accelerate the commercialization of its AI-driven predictive model services

Predictive Oncology Inc. (NASDAQ: POAI) has announced the latest development in its mission to become the leader in the cancer precision-medicine field. In line with its focus on applying artificial intelligence (AI) to personalized medicine and drug discovery, POAI has signed a signed a Letter of Intent to acquire Quantitative Medicine (QM), a leading biomedical analytics and computational biology company (http://nnw.fm/svTl8).

Founded by Drs. Robert Murphy and Joshua Kangas, both of Carnegie Mellon University, QM has developed a novel, computational drug-discovery platform called CoRE. This innovative platform predicts the main effects of drugs on target molecules that mediate disease, thereby dramatically reducing the time, cost and financial risk of discovering new therapeutic drugs. POAI’s planned acquisition of QM, which is subject to the negotiation of a definitive agreement and other terms and conditions, is expected to be complete by March 2020.

“By coupling QM’s CoRE predictive modeling platform with our tumor profiling expertise and data we believe we can revolutionize the way precision therapies are developed,” Dr. Carl Schwartz, president and CEO of Predictive Oncology, stated in a news release. Schwartz explained that the synergies created by the planned acquisition should be a major support in POAI’s efforts to accelerate the commercialization of its AI-driven technology and services.

Through its subsidiary Helomics, Predictive Oncology is building AI-driven predictive models of tumor drug response and outcomes from its data base of drug-response and genomics profiles gathered from more than 150,000 cancer cases. POAI plans to integrate its proprietary data and AI-driven predictive models with CoRE to rapidly build robust predictive models of how specific types of tumors will react to cancer drug therapies.

“Our goal is to provide researchers in pharma, biopharma and diagnostic companies with actionable insights that will not only drive the development of new precision therapies, companion diagnostics, and biomarkers, but will also help them design better targeted trials,” added Schwartz. “Working together, we have the potential to dramatically improve patient outcomes.”

CoRE was developed at what was originally the Ray and Stephanie Lane Center for Computational Biology; the center eventually became the Computational Biology Department at Carnegie Mellon University. CoRE has been tested by several pharma companies with considerable success. In addition to predicting the main effects of drugs on target molecules that mediate disease, CoRE is designed to predict the effects of drugs on other molecules or pathways in the body that could mediate adverse effects, as well as the interaction of these with underlying genetic variations.

Moreover, CoRE identifies similarities in relationships of drug candidates screened against a diverse matrix of pathogenic, cellular, molecular and/or systems biology targets. Drawing on CoRE’s unmatched ability to add new data from existing research or additional wet-lab experiments, POAI is confident that its predictive models will be improved—and with improved predictions comes accelerated drug discovery and development.

POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through its Helomics division, the company leverages its unique, clinically validated patient derived (PDx) smart tumor profiling platform to provide oncologists with a roadmap to help individualize therapy. In addition, the company is leveraging artificial intelligence and its proprietary database of over 150,000 cancer cases tumors to build AI-driven models of tumor drug repose to improve outcomes for the patients of today and tomorrow.

For more information, visit the company’s website at www.Predictive-Oncology.com

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://nnw.fm/POAI

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Thursday, March 5th, 2020 Uncategorized Comments Off on $POAI LOI for Acquisition of Biomedical Analytics with Novel Drug-Discovery Platform

$SGLB Joint Sales Agreement with $MTLS, PrintRite3D + MCP Controller

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, today announced that it has entered into a binding joint sales agreement with Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services. Per the update, the companies have agreed to advance the previously announced memorandum of understanding (“MOU”) to work together to integrate the Materialise Control Platform (“MCP”) product with Sigma Labs’ PrintRite3D(R) technology. Through the joint sales agreement, the companies have agreed to carry out beta customer commercialization of the integrated PrintRite3D(R) and Materialise MCP Controller to offer a unique product solution for retrofit of existing machines, OEM machine integration and closed loop control. “Growing our partnership with Materialise is a significant milestone for Sigma Labs as we expand our footprint in the market and add momentum to our quest to broaden industry access to our groundbreaking PrintRite3D(R) software,” Sigma Labs executive chairman Mark K. Ruport stated in the news release. “The alignment is a natural step for both companies, as Materialise has a strong presence in the additive manufacturing market and a reputation for quality products. Commercializing and jointly selling this integrated solution will benefit both companies as well as advance the forward momentum of innovation in the 3D manufacturing industry.”

To view the full press release, visit http://nnw.fm/Qle4w

About Sigma Labs

Sigma Labs, Inc. (NASDAQ: SGLB) is a leading provider of quality assurance software to the commercial 3D printing industry under the PrintRite3D(R) brand. Founded in 2010, Sigma is a software company that specializes in the development and commercialization of real-time computer aided inspection (“CAI”) solutions known as PrintRite3D(R) for 3D advanced manufacturing technologies. Sigma Labs’ advanced computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance mid-production, uniquely allowing errors to be corrected in real-time. For more information, please visit www.SigmaLabsInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://nnw.fm/SGLB

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Thursday, March 5th, 2020 Uncategorized Comments Off on $SGLB Joint Sales Agreement with $MTLS, PrintRite3D + MCP Controller

$SRAX Data-Management Technology Set to Rise with Consumers’ Increasing Desire for Privacy

SRAX (NASDAQ: SRAX), a digital marketing and consumer-data-management technology company, is well positioned as a rising number of consumers are demanding that their data be kept private. An article discussing the company reads, “In addition to simply desiring privacy, this movement also stems from a growing awareness of the value of that data. The California Consumer Privacy Act (‘CCPA’) was created in response to the public’s demands. The law took effect on January 1, 2020, and created new consumer rights relating to access, deletion and sharing of personal information collected by businesses. Consumers are concerned that smart devices in their homes are being used to track excessive information and that advertisers have access to that data. . . . ‘The goal of the CCPA was to reign in the power that companies like Facebook have over consumers,’ SRAX COO Kristoffer Nelson stated in a news release (http://nnw.fm/uD90z). Ironically, Google and Facebook might actually be exempt from the CCPA. Nelson went on to explain that the law was written by well-meaning people who simply did not have a full understanding of the technology, data or advertising. . . . ‘The law that was created to challenge big-tech surveillance further entrenches these legacy incumbents while harming small businesses and publishers,’ Nelson continued. ‘But the law is now in effect, and the industry must comply.’ The good news is that the law will create a better internet experience for the consumer by forcing a more transparent and balanced relationship between the consumer and the company.”

To view the full article, visit http://nnw.fm/5b73S

About SRAX Inc.

SRAX Inc. (NASDAQ: SRAX) is a digital marketing and consumer-data-management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and the characteristics of those consumers across marketing channels. Monetizing its data sets, SRAX is growing multiple recurring revenue streams through various platforms. Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby offering everyone in the internet ecosystem choice, transparency and compensation. SRAX’s tools deliver a digital competitive advantage for brands in the CPG, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform. For more information on SRAX, visit www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Wednesday, March 4th, 2020 Uncategorized Comments Off on $SRAX Data-Management Technology Set to Rise with Consumers’ Increasing Desire for Privacy

$POAI Key Focus Areas, Precision Medicine and AI, Among Top Industry Investment Trends

March 4, 2020

  • Precision medicine, AI among top healthcare investment trends for 2020
  • Predictive Oncology is data, AI-driven precision medicine company with an exclusive database of patient samples
  • Market estimates for precision medicine expected to reach $84.6 billion by 2024

Precision medicine and artificial intelligence rank high on the list of top investment-focused healthcare trends, according to a recent Emagine article (http://nnw.fm/jKVt0). Both are key areas of focus for Predictive Oncology Inc. (NASDAQ: POAI), a leading data and artificial-intelligence-driven precision medicine company. In an arena where data is king and artificial intelligence is increasingly gravitating to the spotlight, POAI is uniquely positioned with its historic database of patient samples and its cutting-edge AI-powered platform.

“We’ll see more progress in the next 10 years than we’ve seen in the past 50,” stated industry analyst Bill Gadless, who compiled the list of industry trends after attending the 38th annual J.P. Morgan Healthcare Conference. Gadless noted that the hot trends focus on “continuing to save, extend and improve lives.”

The annual conference, the largest and most informative healthcare investment symposium in the industry, brings together industry leaders, innovative technology creators, emerging fast-growth companies and other members of the investment community. Precision medicine received significant interest with its focus on matching up patients with precisely targeted treatments tailored to their unique genetic makeup. At the same time, AI was highlighted as an emerging and increasingly significant tool for use in clinical trials, practice management and digital-health diagnostics.

Emerging as one to watch in the industry, Predictive Oncology is bringing its cutting-edge technology to help pharmaceutical, diagnostic and biotech companies develop new therapies. Through its subsidiary Helomics, a leader in AI and functional precision medicine, POAI harnesses rich patient information gleaned from its PDx tumor profiling platform with the potential to revolutionize cancer research as it is seen today. Through the development of AI-driven predictive models that indicate how tumors respond to drugs, POAI will support clinicians in making decisions to individualize patient treatment. Additionally, these AI-driven models, together with the PDx tumor profiling platform can accelerate research into new targeted therapies.

Drug development for cancer treatment is a costly and time-intensive endeavor – the average drug takes upwards of 10 years and $3 billion to produce – and as technology plays an ever-increasing role in driving medicine, researchers and clinicians are discovering the significant potential of patient-derived PDx models in understanding the activity of potential new drugs on tumors. These models harness cancer cells from patient tumors to create a truly patient-centric future of precision medicine.

As a striking example of this intersection of research and technology, POAI’s Helomics clinical PDx platform compares the drug response and genomic profile of a patient’s own tumor grown in the lab with its database of over 150,000 existing tumor profiles to help recommend the best treatment for that patient. As additional patient samples are tested, they continue to enhance the database improving the recommendations. Leveraging the rich data in this database with AI to create AI-driven predictive models provides a valuable tool for pharmaceutical companies and researchers, offering a model that embodies actual drug response of cancer patients’ individual tumors and their outcomes (i.e. survival). This ability to build AI-driven predictive models of cancer puts the company in a powerful position to offer actionable insights to pharmaceutical companies much more quickly than its competitors.

According to Mordor Intelligence Inc., oncology is expected to have the largest share of the precision medicine market in excess of 30% over other segments, along with a CAGR of 10.3% from 2018 to 2024 (http://nnw.fm/aLp0V). Eyeing the projected overall market estimate of $84.6 billion by 2024, POAI is positioning itself to capture a considerable portion of this growth potential with its unique proprietary technology.

For more information, visit the company’s website at www.Predictive-Oncology.com

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://nnw.fm/POAI

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Wednesday, March 4th, 2020 Uncategorized Comments Off on $POAI Key Focus Areas, Precision Medicine and AI, Among Top Industry Investment Trends

$GNPX CEO Presenting at the 2020 LD Micro Virtual Conference

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing treatments for cancer and other serious diseases, this morning announced that the company’s chairman and chief executive officer Rodney Varner will be leading a presentation and answering questions from investors at the third annual LD Micro Virtual Conference. The company’s presentation is scheduled to take place on Wednesday, March 4 at 1:40 PM EST. The conference will showcase over 40 companies in the small/micro-cap space and will be held via webcast. “We are delighted to be hosting our third virtual event in order to showcase some of the truly unique names in micro-cap,” “There are many people and companies who are unable to attend our live events due to any number of reasons, so we are happy to offer an additional way for companies to present to investors without taking a lot of time out of their day-to-day operations. While virtual events will never replace the experience of sitting in the same room as other humans, it is a great format for updating the investor community and getting increased exposure,” LD Micro president Chris Lahiji stated in the news release.

To access the live presentation, visit http://nnw.fm/9Ny2z

To view the full press release, visit http://nnw.fm/Vo7V8

About Genprex, Inc.

Genprex, Inc. is a clinical-stage gene therapy company developing potentially life-changing treatments for cancer and other serious diseases. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and other serious diseases who currently have limited treatment options. Genprex works with world-class institutions and collaborators to in-license and develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches for patients with cancer and other serious diseases. The company’s lead product candidate, Oncoprex(TM) immunogene therapy for non-small cell lung cancer (“NSCLC”), uses the company’s unique, proprietary platform which delivers cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. In January 2020, the FDA granted Fast Track Designation for Oncoprex in combination with AstraZeneca’s Tagrisso(R) for the treatment of NSCLC. For more information, please visit the company’s website at www.Genprex.com.

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://nnw.fm/GNPX

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Wednesday, March 4th, 2020 Uncategorized Comments Off on $GNPX CEO Presenting at the 2020 LD Micro Virtual Conference

$SRAX BIGtoken Platform Powers Kraft Heinz Holiday Campaign

March 3, 2020

  • BIGtoken case study reports that Kraft Heinz’s 2019 Walmart holiday promotion achieved 4.5% additional volume, six times return on ad spend
  • BIGtoken co-founder says platform has evolved into “full-service marketing stack” that discovers “profound insights” about target audience
  • SRAX’s proprietary consumer data management technology put consumers’ data rights at the forefront

SRAX Inc.’s (NASDAQ: SRAX) BIGtoken platform successfully propelled a 2019 holiday season omnichannel campaign at Walmart for leading packaged goods company Kraft Heinz – achieving impressive results and exceeding the client’s goals. SRAX COO Kristoffer Nelson said BIGtoken utilized opt-in panels and offers plus scanned receipts to identify incremental groups of buyers to increase both sales and return on ad spend for Kraft Heinz.

The case study outlining the successful campaign demonstrates how BIGtoken was able to not only identify known customers but also target incremental groups of likely Kraft Heinz buyers (http://nnw.fm/J3PWu). The resulting high-value customer insights fueled enhanced audience targeting and messaging – yielding an impressive 4.5% sales lift and a six-to-one return on ad spend (ROAS).

“It’s important for Kraft Heinz to address data accuracy, consumer privacy and emphasize first-party data in this new environment,” said TJ Palladino, Walmart shopper marketing manager for Kraft Heinz. “BIGtoken does all of that. We are thrilled with the results we saw with SRAX’s BIGtoken platform.”

Pre-launch activity by BIGtoken includes numerous data points about the identity habits of consumers. For its promotion, Kraft Heinz used the BIGtoken platform to identity common attributes around consumers who cook meals for key groups during the holiday season.

Kraft Heinz’s successful Walmart promotion featured prominent brands such as Kraft, Velveeta, Oscar-Mayer, Heinz and Stove Top. SRAX’s BIGtoken platform was able to create and identify audiences and design an effective messaging strategy around those brands.

“BIGtoken has evolved from a consumer, opt-in, data platform for advertising activation to a full-service marketing stack,” SRAX COO Kristoffer Nelson stated in a news release (http://nnw.fm/4ruSu). “Beginning with audience insights, marketers can discover profound insights about their target audience to activate against. From here, new insights and learnings are applied inflight to improve performance.”

BIGtoken Brands VP George Stella added, “It’s becoming critical for brands to partner with systems that put emphasis on consumer-first data particles and put consumers’ data rights at the forefront.”

For more information, visit the company’s website at www.SRAX.com

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Tuesday, March 3rd, 2020 Uncategorized Comments Off on $SRAX BIGtoken Platform Powers Kraft Heinz Holiday Campaign